Inclusion criteria were endometrial cancer with cervical stromal invasion, FIGO 2009 stage II, III, or IV. Exclusion criteria were invasive synchronous cancer and receipt of neoadjuvant therapy.

The molecular heterogeneity of endometrial stromal tumors (ESTs) is demonstrated by the presence of the same fusion gene in distinct pathologic entities, such as endometrial nodules and low-grade ...

They account for approximately 1% of all uterine malignant neoplasms and 10-25% of uterine mesenchymal tumors. The 2020 WHO classification system recognizes four subgroups: Endometrial stromal nodule ...

Endometrial cancer—in which tumors develop in the inner lining of the uterus—is the most prevalent gynecological cancer in ...

Background: Endometrial stromal sarcoma (ESS) is a rare uterine neoplasm. Most studies included uterine sarcomas of different histologic types. The prognostic factors and long-term outcome for ESS are ...

In a study of patients with endometrial stromal sarcomas treated with aromatase inhibitors the objective response rate was more modest than expected, but a majority did achieve stable disease ...

A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

Endometrial cancer (EC) is one of the most prevalent malignancies of the female reproductive system and ranks among the three primary types of gynecological cancers. Recent trends indicate a rising ...

A new case report was published in Volume 12 of Oncoscience on July 2, 2025, titled "Navigating diagnostic complexity: A case report on uterine lipoleiomyoma, unveiling its benign nature amidst ...

Organoid co-culture model of the human endometrium in a fully synthetic extracellular matrix enables the study of epithelial-stromal crosstalk. Med, 2023; 4 (8): 554 DOI: 10.1016/j.medj.2023.07.004 ...